Stocks Comparison
Intellia Therapeutics vs Alpha Teknova: revenue, profit, margins and growth compared
Intellia Therapeutics brought in $67.7M of revenue in fiscal 2025, Alpha Teknova $40.5M in fiscal 2025. Revenue changed by +16.9% at Intellia Therapeutics and +7.4% at Alpha Teknova on the year before, so Intellia Therapeutics grew faster. Intellia Therapeutics kept -609.9% of its revenue as net profit, Alpha Teknova -42.6%. Free cash flow was -$395.9M at Intellia Therapeutics and -$9.8M at Alpha Teknova.
Side by side, latest fiscal year
| NTLA | TKNO | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $67.7M | $40.5M |
| Revenue growth | +16.9% | +7.4% |
| Net income | -$412.7M | -$17.3M |
| Net margin | -609.9% | -42.6% |
| Free cash flow | -$395.9M | -$9.8M |
| Free cash flow margin | -585.0% | -24.2% |
| Earnings per share (diluted) | -$3.81 | -$0.32 |
| Cash | $155.5M | $5.9M |
| Debt | n/a | $13.1M |
| Price to earnings | n/a | n/a |
| Market value | $1.6B | $500.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #339 of 523 · Health care | #376 of 523 · Health care |
Over the years
Questions about Intellia Therapeutics and Alpha Teknova
Which is bigger by revenue, Intellia Therapeutics or Alpha Teknova?
Intellia Therapeutics is bigger by revenue: $67.7M in fiscal 2025, against $40.5M for Alpha Teknova in fiscal 2025.
Which keeps more of its revenue as profit, Intellia Therapeutics or Alpha Teknova?
Intellia Therapeutics had a net margin of -609.9% in fiscal 2025; Alpha Teknova had -42.6% in fiscal 2025.
Which grew revenue faster, Intellia Therapeutics or Alpha Teknova?
In their latest fiscal years revenue changed by +16.9% at Intellia Therapeutics and +7.4% at Alpha Teknova.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.